Current trends in the treatment of hepatocellular carcinoma with transarterial embolization: a cross-sectional survey of techniques
Authors:
- 22 October 2018
- journal article
- research article
- Published by Springer Nature in European Radiology
- Vol. 29 (6) , 3287-3295
Abstract
Despite being accepted as a mainstay of treatment for hepatocellular carcinoma (HCC), technical aspects of transarterial chemoembolization (TACE) continue to vary by reporting author, leading to heterogeneity in the literature and making meaningful comparisons between treatments difficult. The goal of this survey was to report international chemoembolization practices for the treatment of HCC in an effort to understand current treatment strategies as a first step towards technique standardization.Keywords
This publication has 30 references indexed in Scilit:
- Trends in Utilization of Transarterial Treatments for Hepatocellular Carcinoma: Results of a Survey by the Italian Society of Interventional RadiologyCardioVascular and Interventional Radiology, 2013
- Conventional versus Doxorubicin-eluting Bead Transarterial Chemoembolization for Hepatocellular CarcinomaJournal of Vascular and Interventional Radiology, 2011
- A Randomized Phase II Study of Drug-Eluting Beads versus Transarterial Chemoembolization for Unresectable Hepatocellular CarcinomaOnkologie, 2011
- Comparative Study of Chemoembolization Loadable Beads: In vitro Drug Release and Physical Properties of DC Bead and Hepasphere Loaded with Doxorubicin and IrinotecanJournal of Vascular and Interventional Radiology, 2010
- Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V StudyCardioVascular and Interventional Radiology, 2009
- Hepatocellular Carcinoma: Epidemiology and Molecular CarcinogenesisGastroenterology, 2007
- DC Bead: In Vitro Characterization of a Drug-delivery Device for Transarterial ChemoembolizationJournal of Vascular and Interventional Radiology, 2006
- Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinomaHepatology, 2002
- Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trialThe Lancet, 2002
- Segmental Transcatheter Hepatic Artery Chemoembolization with Iodized Oil for Hepatocellular Carcinoma: Antitumor Effect and Influence on Normal TissueJournal of Vascular and Interventional Radiology, 1993